[The effect of antioxidant therapy on some pathogenetic factors of primary open-angle glaucoma].

The drug Mexidol proved to be an effective endothelial protector, a powerful antioxidant and antihypoxant, contributed to deceleration of atherogenesis in patients with POAG.